- Home
- UNCY vs GDO Comparison
UNCY vs GDO Comparison
Compare UNCY & GDO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNCY
- GDO
- Stock Information
- Founded
- UNCY 2016
- GDO 2009
- Country
- UNCY United States
- GDO United States
- Employees
- UNCY N/A
- GDO N/A
- Industry
- UNCY Biotechnology: Pharmaceutical Preparations
- GDO Finance Companies
- Sector
- UNCY Health Care
- GDO Finance
- Exchange
- UNCY Nasdaq
- GDO Nasdaq
- Market Cap
- UNCY 71.8M
- GDO 82.4M
- IPO Year
- UNCY 2021
- GDO N/A
- Fundamental
- Price
- UNCY $0.62
- GDO $11.41
- Analyst Decision
- UNCY Strong Buy
- GDO
- Analyst Count
- UNCY 3
- GDO 0
- Target Price
- UNCY $5.50
- GDO N/A
- AVG Volume (30 Days)
- UNCY 510.7K
- GDO 39.4K
- Earning Date
- UNCY 05-16-2025
- GDO 01-01-0001
- Dividend Yield
- UNCY N/A
- GDO 9.81%
- EPS Growth
- UNCY N/A
- GDO N/A
- EPS
- UNCY N/A
- GDO N/A
- Revenue
- UNCY N/A
- GDO N/A
- Revenue This Year
- UNCY N/A
- GDO N/A
- Revenue Next Year
- UNCY $1,502.84
- GDO N/A
- P/E Ratio
- UNCY N/A
- GDO N/A
- Revenue Growth
- UNCY N/A
- GDO N/A
- 52 Week Low
- UNCY $0.20
- GDO $11.21
- 52 Week High
- UNCY $1.16
- GDO $13.04
- Technical
- Relative Strength Index (RSI)
- UNCY 51.83
- GDO 55.24
- Support Level
- UNCY $0.59
- GDO $11.35
- Resistance Level
- UNCY $0.66
- GDO $11.50
- Average True Range (ATR)
- UNCY 0.03
- GDO 0.13
- MACD
- UNCY -0.00
- GDO 0.04
- Stochastic Oscillator
- UNCY 40.05
- GDO 76.85
About UNCY Unicycive Therapeutics Inc.
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. It is focusing on kidney diseases. The company's manufactures drug, Renazorb, is a novel phosphate-binding agent being developed for the treatment of hyperphosphatemia. Unicycive's other drug, UNI-494, is a new chemical entity with the issued composition of matter patent protection in late preclinical development for the treatment of acute kidney injury. Company's pipeline comprised of two product candidates: Oxylanthanum Carbonate and UNI-494.
About GDO Western Asset Global Corporate Defined Opportunity Fund Inc.
Western Asset Global Corp Defined Opp is a closed-end management investment company with a primary investment objective to provide current income. Its secondary objective is to seek capital appreciation. The Fund invests in the United States and foreign corporate fixed-income securities of varying maturities.